Skip to contentC
CV Sciences, Inc.
C
CVSICV Sciences, Inc. Q2 2014 · 10-Q
Revenue$3.01M$3.01M+2,691.3% vs Q2 2013 Net Income$8.04M$8.04MN/M vs Q2 2013 EPS Diluted$0.24$0.24N/M vs Q2 2013 Gross Profit$1,795,816+1,865.0% Operating Income
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
CV Sciences, Inc. · CIK 1510964 · Engraved from SEC EDGAR
Operating Cash Flowderived-$140,933N/M Free Cash Flowderived-$345,497N/M Margins · derivedGross margin59.7%−25.1 pt vs Q2 2013
Operating margin4.4%+308.6 pt vs Q2 2013
Net margin267.5%+590.8 pt vs Q2 2013
ended Jun 30, 2014 · filed Aug 14, 2014 · 45 d after period end